These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5935864)

  • 21. [Effectiveness of isosorbide dinitrate and pentaerythritol tetranitrate by means of acute determination of the coronary reserve on cycloergometer in patients with stable angina pectoris].
    Poprawski K
    Pol Arch Med Wewn; 1979 Sep; 62(3):221-9. PubMed ID: 523326
    [No Abstract]   [Full Text] [Related]  

  • 22. Exercise tolerance in patients with angina pectoris: daily variation and effect of pentaerythritol tetranitrate.
    Dagenais GR; Mason RE; Friesinger GC; Wender C; Ross RS
    Johns Hopkins Med J; 1969 Dec; 125(6):301-11. PubMed ID: 4905736
    [No Abstract]   [Full Text] [Related]  

  • 23. Drugs for prophylaxis of angina pectoris.
    Med Lett Drugs Ther; 1975 Jul; 17(14):57-8. PubMed ID: 805906
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of angina pectoris with Dilcoran 80].
    Strickler W
    Landarzt; 1967 Oct; 43(30):1485-9. PubMed ID: 5609195
    [No Abstract]   [Full Text] [Related]  

  • 25. [Angina pectoris: clinical estimation of prophylaxis in open units].
    Finnson M; Nyberg G
    Lakartidningen; 1969 Dec; 66(49):5137-45. PubMed ID: 4908066
    [No Abstract]   [Full Text] [Related]  

  • 26. [Nitro-sandolanid in angina pectoris].
    Stieglitz T
    Med Welt; 1973 Apr; 24(16):655-6. PubMed ID: 4756332
    [No Abstract]   [Full Text] [Related]  

  • 27. Contact dermatitis due to nitroglycerin ointment.
    Hendricks AA; Dec GW
    Arch Dermatol; 1979 Jul; 115(7):853-5. PubMed ID: 110268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of expiring reimbursability of pentaerythrityl tetranitrate (PETN, pentalong®) on anti-anginal therapy: an observational study.
    Grimmsmann T; Chenot JF; Angelow A
    Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):803-11. PubMed ID: 26043680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative evaluation of the clinical effectiveness and the adverse effects of three different forms of nitrates in high oral doses in patients with stable angina pectoris].
    Kośmicki M; Kowalik I; Jedrzejczyk B; Sadowski Z
    Pol Arch Med Wewn; 2002 Jun; 107(6):509-17. PubMed ID: 12371383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Value of nitrate derivatives at high doses in the treatment of angina pectoris: apropos of a statistical study of 100 patients].
    Perrin A
    Sem Ther; 1966 Oct; 42(8):419-22. PubMed ID: 5994377
    [No Abstract]   [Full Text] [Related]  

  • 31. [Constant-frequency trans-esophageal electric atrial stimulation for evaluation of the severity of illness in patients with stenocardia and the anti-angina effect of erinit].
    Gasilin VS; Sidorenko BA; Lazarev IA; Smirnov MIu
    Kardiologiia; 1990 Dec; 30(12):27-30. PubMed ID: 2097391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of perhexiline maleate in patients with angina pectoris unrelieved by other antianginal agent.
    Alcocer L; Aspe J; Arce-Gomez E
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):349-57. PubMed ID: 4198295
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical data on 20 patients treated with the association of butydrine and pentaerythritol tetranitrate].
    Rossi PL; Guarraggi A; Anfossi F
    Clin Ter; 1971 May; 57(4):345-50. PubMed ID: 5110948
    [No Abstract]   [Full Text] [Related]  

  • 34. [Anti-anginal activity of a beta-adrenergic blocking agent, butydrine, alone and in association with pentaerythritol tetranitrate, in the aged].
    Gatti A; Scotti G
    Clin Ter; 1967 May; 41(4):363-74. PubMed ID: 5614306
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of coronary insufficiency].
    Semmler F
    Ther Ggw; 1967 May; 106(5):673 passim. PubMed ID: 5622746
    [No Abstract]   [Full Text] [Related]  

  • 36. [Coronary therapy with Nitro-Sandolanid].
    Jung A
    Ther Ggw; 1970 Feb; 109(2):237-46. PubMed ID: 5441695
    [No Abstract]   [Full Text] [Related]  

  • 37. [Conservative therapy of angina pectoris].
    Nager F
    Schweiz Med Wochenschr; 1970 May; 100(20):855-61. PubMed ID: 4997632
    [No Abstract]   [Full Text] [Related]  

  • 38. Antianginal effect of transdermal nitroglycerin and oral nitrates given for 24 hours a day in 2,456 patients with stable angina pectoris. The Italian Multicenter Study.
    Savonitto S; Motolese M; Agabiti-Rosei E
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):194-203. PubMed ID: 7620688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Special place of PETN among nitrates. No tolerance development, fewer headaches].
    Münzel T
    MMW Fortschr Med; 2008 Jan; 150(1-2):41. PubMed ID: 18300643
    [No Abstract]   [Full Text] [Related]  

  • 40. [Combination therapy of angina pectoris vera with coronary active substances and Faustan].
    Nossing R; Gruber G; Schmidt P
    Z Arztl Fortbild (Jena); 1971 Jun; 65(12):589-91. PubMed ID: 5000186
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.